Media
Careers
Contacts

CBP - Pioneering and developing Bi-targeting XDC technology

Pioneering and developing Bi-targeting XDC technology

Who We Are
Science & Innovation
Pipeline
For Patient

Author Archives: admin

1 2 3 … 5 Next page

Categories

News 25

Recent Posts

The U.S. FDA Grants Fast Track Designation to Coherent Biopharma’s CBP-1008October 12, 2024
Coherent Biopharma’s CBP-1019 has received Orphan Drug Designation from the FDA for three indicationsJune 26, 2024
ASCO 2024 Highlights: Research findings of CBP-1008 and CBP-1018 once again attract global attentionJune 5, 2024
【AACR 2024】Coherent Biopharma Announced Latest Pipeline CBP-8008 Preclinical Research ProgressApril 10, 2024
CoherentBiopharma made its appearance at the 14th World ADC Conference in LondonMarch 16, 2024

Archives

2024 (5)
2023 (6)
2022 (4)
2021 (3)
2020 (4)
2019 (1)
2018 (2)

Meet CBP

Leadership
Our History
Our Culture

Science&Innovation

Approach
Platforms
World of Bi-XDC

Pipeline

Pipeline
Clinical Trials
Publications

For Patient

Patient Safety
Clinical Sites
Expanded Access Policy

Copyright © 2024 CBP All rights reserved.